THC(THC)
THC
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $22.18B | $22.48B | $23.51B | $24.09B |
| Low | $22.00B | $21.97B | $22.97B | $23.58B |
| High | $22.38B | $23.11B | $24.48B | $25.16B |
| EBITDA Avg | $7.00B | $7.10B | $7.43B | $7.61B |
| Low | $6.95B | $6.94B | $7.26B | $7.45B |
| High | $7.07B | $7.30B | $7.73B | $7.95B |
| EBIT Avg | $6.21B | $6.30B | $6.59B | $6.75B |
| Low | $6.16B | $6.16B | $6.44B | $6.61B |
| High | $6.27B | $6.48B | $6.86B | $7.05B |
| Net Income Avg | $1.77B | $1.63B | $2.05B | $2.61B |
| Low | $1.60B | $1.49B | $1.76B | $2.54B |
| High | $2.09B | $2.15B | $2.34B | $2.76B |
| EPS Avg | $20.76 | $20.59 | $22.43 | $28.72 |
| Low | $17.60 | $16.35 | $19.38 | $27.94 |
| High | $23.00 | $23.64 | $25.73 | $30.39 |
| Analysts (Rev / EPS) | 14 / 11 | 15 / 12 | 13 / 5 | 11 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $5.48B | $5.73B | $5.43B | $5.58B | $5.50B | $5.77B | $5.68B | $5.78B |
| Low | $5.45B | $5.66B | $5.36B | $5.51B | $5.43B | $5.69B | $5.61B | $5.70B |
| High | $5.50B | $5.81B | $5.64B | $5.79B | $5.71B | $5.99B | $5.90B | $6.00B |
| EBITDA Avg | $1.73B | $1.81B | $1.72B | $1.76B | $1.74B | $1.82B | $1.79B | $1.82B |
| Low | $1.72B | $1.79B | $1.69B | $1.74B | $1.72B | $1.80B | $1.77B | $1.80B |
| High | $1.74B | $1.84B | $1.78B | $1.83B | $1.80B | $1.89B | $1.86B | $1.89B |
| EBIT Avg | $1.54B | $1.61B | $1.52B | $1.56B | $1.54B | $1.62B | $1.59B | $1.62B |
| Low | $1.53B | $1.59B | $1.50B | $1.54B | $1.52B | $1.59B | $1.57B | $1.60B |
| High | $1.54B | $1.63B | $1.58B | $1.62B | $1.60B | $1.68B | $1.65B | $1.68B |
| Net Income Avg | $384M | $465M | $401M | $445M | $394M | $470M | $414M | $452M |
| Low | $354M | $403M | $394M | $437M | $387M | $463M | $407M | $445M |
| High | $442M | $594M | $421M | $467M | $413M | $494M | $434M | $475M |
| EPS Avg | $4.58 | $5.54 | $4.77 | $5.29 | $4.69 | $5.60 | $4.92 | $5.39 |
| Low | $4.21 | $4.80 | $4.70 | $5.21 | $4.61 | $5.51 | $4.84 | $5.30 |
| High | $5.27 | $7.07 | $5.01 | $5.56 | $4.92 | $5.88 | $5.17 | $5.66 |
| Analysts (Rev / EPS) | 11 / 12 | 11 / 12 | 5 / 5 | 5 / 5 | 8 / 5 | 5 / 5 | 4 / 6 | 5 / 6 |